{"url_path":"/sec/bmrn/8-k/2026-04-27/item-2-01","section_key":"item-2-01","section_title":"Item 2.01 Completion of Acquisition or Disposition of Assets.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1048477/0001193125-26-179243-index.html","accession_number":"0001193125-26-179243","cik":"0001048477","ticker":"BMRN","issuer_name":"BIOMARIN PHARMACEUTICAL INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1048477/0001193125-26-179243-index.html","primary_entity_key":"0001048477","primary_entity_name":"BIOMARIN PHARMACEUTICAL INC"},"word_count":375,"has_tables":true,"body_markdown":"Item 2.01\n\nCompletion of Acquisition or Disposition of Assets.\n\nThe information set forth in the “Introductory Note” above is incorporated into this Item 2.01 by reference.\n\nAt the effective time of the Merger (the “Effective Time”), each share of common stock, par value $0.01 per share, of Amicus (“Amicus Common Stock”) issued and outstanding immediately prior to the Effective Time (other than certain excluded shares as described in the Merger Agreement) was automatically cancelled and converted into the right to receive $14.50 in cash, without interest thereon and subject to any applicable withholding of taxes.\n\nPursuant to the Merger Agreement, at the Effective Time, (i) each outstanding and unexercised Amicus option awarded, whether or not vested, and which had a per share exercise price that was less than $14.50 (each, an “In-the-Money Option”) was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess of (x) $14.50 over (y) the exercise price payable per share under such Amicus option multiplied by (B) the total number of shares subject to such Amicus option (without regard to vesting); (ii) each outstanding and unexercised Amicus option awarded other than an In-the-Money Option, whether or not vested, was cancelled with no consideration payable in respect thereof; (iii) each outstanding Amicus restricted stock unit awarded was cancelled and the holder thereof was entitled to receive a cash payment in the amount equal to the product of $14.50 multiplied by the number of shares of Amicus Common Stock subject to such Amicus restricted stock unit; and (iv) each outstanding Amicus performance-vesting restricted stock unit awarded, whether or not vested, was cancelled and the holder thereof was entitled to receive a cash payment in the amount equal to the product of $14.50 multiplied by the number of shares of Amicus Common Stock subject to such Amicus performance-vesting restricted stock unit (as determined at the level of performance set forth in the Merger Agreement and without any pro-ration).\n\nThe foregoing description of the Merger Agreement and the transactions contemplated thereby does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, which is included as Exhibit 2.1 hereto and incorporated herein by reference."}